These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 18940194

  • 1. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
    Labrie V, Clapcote SJ, Roder JC.
    Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
    [Abstract] [Full Text] [Related]

  • 2. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.
    Labrie V, Lipina T, Roder JC.
    Psychopharmacology (Berl); 2008 Oct; 200(2):217-30. PubMed ID: 18597079
    [Abstract] [Full Text] [Related]

  • 3. Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.
    Labrie V, Wang W, Barger SW, Baker GB, Roder JC.
    Genes Brain Behav; 2010 Feb; 9(1):11-25. PubMed ID: 19751394
    [Abstract] [Full Text] [Related]

  • 4. Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity.
    Zhang M, Ballard ME, Basso AM, Bratcher N, Browman KE, Curzon P, Konno R, Meyer AH, Rueter LE.
    Behav Brain Res; 2011 Feb 02; 217(1):81-7. PubMed ID: 20933022
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia.
    Labrie V, Roder JC.
    Neurosci Biobehav Rev; 2010 Mar 02; 34(3):351-72. PubMed ID: 19695284
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT, Nunes-de-Souza RL.
    Brain Res; 2008 Nov 13; 1240():39-46. PubMed ID: 18793618
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
    Manahan-Vaughan D, Wildförster V, Thomsen C.
    Eur J Neurosci; 2008 Oct 13; 28(7):1342-50. PubMed ID: 18973561
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
    Yang CR, Svensson KA.
    Pharmacol Ther; 2008 Dec 13; 120(3):317-32. PubMed ID: 18805436
    [Abstract] [Full Text] [Related]

  • 19. Mutant mice and rats lacking D-amino acid oxidase.
    Konno R, Hamase K, Maruyama R, Zaitsu K.
    Chem Biodivers; 2010 Jun 13; 7(6):1450-8. PubMed ID: 20564563
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
    Adage T, Trillat AC, Quattropani A, Perrin D, Cavarec L, Shaw J, Guerassimenko O, Giachetti C, Gréco B, Chumakov I, Halazy S, Roach A, Zaratin P.
    Eur Neuropsychopharmacol; 2008 Mar 13; 18(3):200-14. PubMed ID: 17681761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.